PharmaTalkRadio – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

PharmaTalkRadio

Conference Forum

Science

Health & Fitness

Frequency: 1 episode/9d. Total Eps: 503

PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.

Site

RSS

Apple

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

🇺🇸 USA - lifeSciences
14/08/2025
#95
🇺🇸 USA - lifeSciences
13/08/2025
#59
🇺🇸 USA - lifeSciences
11/08/2025
#76
🇩🇪 Germany - lifeSciences
06/07/2025
#98
🇺🇸 USA - lifeSciences
25/06/2025
#82
🇬🇧 Great Britain - lifeSciences
19/06/2025
#90
🇬🇧 Great Britain - lifeSciences
18/06/2025
#84
🇬🇧 Great Britain - lifeSciences
17/06/2025
#67
🇬🇧 Great Britain - lifeSciences
16/06/2025
#49
🇬🇧 Great Britain - lifeSciences
15/06/2025
#43

Spotify

No recent rankings available

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

To improve

Score global : 54%

Publication history

Monthly episode publishing history over the past years.

Year

Episodes published by month in

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

Navigating Data Quality and Scalability Challenges when Using Real-World Data from EHRs

mercredi 14 mai 2025 • Duration 26:39

Summary:
In this podcast from the 2024 CRAACO: Clinical Research as a Care Option conference, Dr Meredith Zozus, UT Health San Antonio, walks through several studies illustrating differences in data quality and scalability using EHRs in the conduct of structured protoocls versus retrospective studies using EHR. The results highlight the important methods and approaches for using EHR data in clinicla studies, which is a key component of integrating care and research.

For more information, go to CRAACOevent.com.

Addressing the Realities of Scaling T-Cell Therapies for Patient Access and Affordability

mercredi 14 mai 2025 • Duration 40:11

Summary:
This podcast delves into the critical challenges of scalability in T-cell therapies (including CAR-T, TILs, and TCR-T). The panelists discuss the primary obstacles hindering the increased availability of T-cell therapies to patients, the most promising upcoming approaches to enhance access, the greatest opportunities to improve efficiencies and scalability, and the developments in the near future that could help meet growing demand.

For more information, go to IO360summit.com.

Vaccine Delivery Innovations

mercredi 26 février 2025 • Duration 29:08

This podcast features a panel discussion from the 2024 PODD Conference with pharma and biotech leaders about the technical innovation in the vaccine space within R&D over the past several years as well as the challenges and opportunities around the uptake and implementation of these technologies. Specifically:

Barriers to implementation of technological advancements
How the vaccine marketplace differs from other therapeutic marketplaces and the drivers of meaningful innovation in the space
How to best develop and position innovative vaccine technologies for success
Unmet needs and opportunities for vaccine technologies
Exciting emerging technologies

To learn more about the PODD conference, please visit Drug-Delivery.org.

Investment Trends in IO

mardi 17 janvier 2023 • Duration 44:48

Moderated by: Axel Hoos, MD, PhD, CEO, Scorpion Therapeutics Panelists: Jonathan Fassberg, Vice Chairman of Healthcare Investment Banking, OppenheimerIrina Margine, PhD, Principal, Biotech Private Equity, Wellington ManagementAsthika Goonewardene, MBA, Managing Director, Senior Biotech Analyst, Truist SecuritiesGraig Suvannavejh, PhD, Managing Director, Equity Research Biopharmaceuticals & Biotechnology, Mizuho Securities USA Learn more about the IO360° Summit at www.io360summit.com

Investment and Collaboration Strategies in Cell and Gene Therapy

lundi 16 janvier 2023 • Duration 41:38

This panel, first recorded at the 2022 IO360° Summit addressed: What are the risks and implications of investing in cell/gene therapy companies who have no clinical data from programs available?Venture company perspectives on what they are investing in and why? • What science needs to be seen in order to invest in either a startup or IPO?What are investors/pharma partners looking for and how does that inform what people should be doing?How do we think about partnerships between organizations? Moderated by: Michael Polansky, CEO, Parker Group Panelists: Mark Bonyhadi, PhD, Senior Advisor, Qiming Venture PartnersElaine Cheung, SVP, Corporate Strategy & Business Development, Lyell ImmunopharmaArjun Goyal, MD, MPhil, MBA, Co-founder and Managing Director, Vida Ventures Learn more about the IO360° Summit at www.io360summit.com

Mechanisms of Immune Evasion Mediated by Hypoxia- Inducible Factors

samedi 14 janvier 2023 • Duration 22:55

In this session, first recorded at the 2022 IO360° Summit, Dr Semenza will talk about how his work is impacting cancer immunotherapy. Dr Semenza’s groundbreaking discovery of hypoxia-inducible factors paves the way for the development of drugs that could kill cancer cells by cutting off the oxygen supply tumors need to grow and improve the response to immunotherapies. Key areas addressed include: Regions of intratumoral hypoxia are a common feature of advanced cancersHypoxia-inducible factors increase the expression of multiple proteins that mediate immune evasionHIF inhibitors stimulate anti-tumor immunity and improve the response to immune checkpoint blockade Gregg Semenza, MD, PhD, Director, Vascular Program, Institute for Cell Engineering and Professor of Genetic Medicine, Johns Hopkins University School of Medicine Learn more about the IO360° Summit at www.io360summit.com

Neoadjuvant Immune Checkpoint Blockade: A Window into Treatment Response and Pri

vendredi 13 janvier 2023 • Duration 26:20

Neoadjuvant (pre-surgical) immune checkpoint blockade may prevent cancer relapse and progression.This treatment approach is now FDA-approved for resectable triple-negative breast cancer, and hundreds of clinical trials in other cancers are ongoing.Surgical resection specimens collected after several weeks of neoadjuvant ICB offer vast opportunities for predictive biomarker discovery and understanding ICB response/resistance. Suzanne Topalian, MD, Associate Director / Professor of Surgery, Bloomberg~Kimmel Institute for Cancer Immunotherapy / Johns Hopkins University Learn more about the IO360° Summit at www.io360summit.com

Regeneron’s Approach to Strategic Collaborations, Licensing and Business Dev.

jeudi 12 janvier 2023 • Duration 21:32

Nouhad Husseini, MBA, SVP, Business Development and Corporate Strategy, Regeneron Pharmaceuticals with Allan Shaw, CFO / Founder & Senior Managing Director, Portage Biotech / Shaw Strategic Capital, LLC Learn more about the IO360 Summit at www.io360summit.com

Panel: Targeted Radiotherapy and the Impact on IO

mercredi 11 janvier 2023 • Duration 30:25

What is the impact of targeted radiotherapy on the immune system?What are the implications for combination IO?Current approaches and future direction Moderated by: Michael Groaning, PhD, Global Medical Affairs Lead, Genitourinary, Amgen Panelists: Charles Glaus, PhD, Sr Director, Radiomics & Radiology Biomarkers, Bayer US-PharmaceuticalsJeff Legos, PhD, MBA, EVP, Global Head of Oncology & Hematology Development , NovartisMatthew Silva, PhD, CEO , InvicroOhad Ilovich, PhD, Senior Director, Translational Sciences, Curie Therapeutics Learn more about the IO360° Summit at www.io360summit.com

What’s Next on the IO Radar? Top 10 Recommendations from Dr Andrew Baum, Citi

mardi 10 janvier 2023 • Duration 26:26

Learn more about the IO360° Summit at www.io360summit.com